Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.
The image shows incubators, commonly utilised in laboratories for various purposes, including culturing cells under controlled conditions of temperature and occasionally humidity.
The incubators in the image could be employed in the CAR-T cell production process, particularly during the phase where engineered T cells are multiplied to large numbers under controlled conditions before being reintroduced into the patient.
Or it could be for a completely separate CBR work stream!
Hopefully we can count prevail as matched funding !
Thank you for your kind words @SocialistB!
Lastly a Ted talk from the creator of the machine !
https://www.ted.com/talks/dan_gibson_how_to_build_synthetic_dna_and_send_it_across_the_internet
No amount of yellow tape in the video was gonna stop the digging - Pretty cool machine !
https://european-biotechnology.com/needful-things/sponsored-publications/sponsored-publication/automate-your-dna-variant-library-synthesis-and-reduce-turnaround-time-from-weeks-and-months-to-days.html
Embarrassed yourself there mate, that's a completely separate topic. Mainly relevant for US markets.
The below link would be more relevant for a spin out... as with anything in life there are benefits and drawbacks.
Back to the drawing board for your de ramp - better luck next time !
https://www.investopedia.com/terms/s/spin-out.asp#:~:text=A%20spinout%20is%20a%20type,and%20associated%20assets%20and%20liabilities.
Sharing from Prevails LinkedIn
https://www.fiercebiotech.com/biotech/gritstone-line-433m-barda-funds-mrna-covid-19-shot-large-scale-trial
Interesting to see BARDA splashing the cash. I bet they will be very excited about CBR!
Congrats to our resident OBD holders - I didnt realise we had so many! Missed that one myself, it goes without saying you know where your profits are always welcome!
Subject to clearing IND and getting good results lets hope we move like OBD!
Vlad active on LinkedIn again…
https://www.linkedin.com/posts/defense-threat-reduction-agency_dtras-25th-anniversary-activity-7114335949827837952-KM9B?utm_source=share&utm_medium=member_ios
Https://www.pm360online.com/pm360s-investor-portfolio-mary-schaheen/
Https://find-and-update.company-information.service.gov.uk/company/08401609/filing-history/MzM5NDkxNDk5OWFkaXF6a2N4/document?format=pdf&download=0
Companies house proving the price paid and the new float. Hopefully this keeps the doubters at bay for the time being. In an ideal world I hope to see Prevail invest further and bring some friends to the party!
Enjoy the weekend all we go again Monday!
If big pharma offer a 10p takeover personally I would feel robbed. That's 110m MCAP ish. For CAR-T alone hundreds of millions and in some cases billions have been thrown at development by the same names !
No the patent is under HEMO so no need to worry
Vlad since deleted the LinkedIn post ! Too slow…. Fastest finger first !
Proof of concept achieved for brain cancer !
Https://m.youtube.com/watch?si=mvI80W8LwZ3jjipl&v=X8tYUMq1Oo0&feature=youtu.be
Extract from the AGM re Max possible dilution ---- RESOLUTION 6 – ALLOTMENT OF SHARE CAPITAL
Resolution 6 grants the Directors general authority to allot ordinary shares in the capital of the Company or to grant rights to subscribe for, or to convert any security into, such shares in the Company up to an aggregate nominal amount of £3,265,830.74, representing approximately one-third of the Company’s current issued share capital.
My own very weak argument here - whilst the tweets dont give us much there certainly is a tone. I dont think he would publish such comments so openly if it were failing in the lab.